Artemisinin-based combination therapy for ... - The Cochrane Library
Artemisinin-based combination therapy for ... - The Cochrane Library
Artemisinin-based combination therapy for ... - The Cochrane Library
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
(... Continued)<br />
Study or subgroup DHA-P AS+MQ Risk Ratio Weight Risk Ratio<br />
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI<br />
Subtotal (95% CI) 219 226 100.0 % 6.19 [ 1.40, 27.35 ]<br />
Total events: 12 (DHA-P), 2 (AS+MQ)<br />
Heterogeneity: not applicable<br />
Test <strong>for</strong> overall effect: Z = 2.41 (P = 0.016)<br />
0.01 0.1 1 10 100<br />
Favours DHA-P Favours AS+MQ<br />
Analysis 1.2. Comparison 1 Dihydroartemisinin-piperaquine vs Artesunate plus mefloquine, Outcome 2<br />
Total Failure (P. falciparum) Day 63 PCR adjusted.<br />
Review: <strong>Artemisinin</strong>-<strong>based</strong> <strong>combination</strong> <strong>therapy</strong> <strong>for</strong> treating uncomplicated malaria<br />
Comparison: 1 Dihydroartemisinin-piperaquine vs Artesunate plus mefloquine<br />
Outcome: 2 Total Failure (P. falciparum) Day 63 PCR adjusted<br />
1 Asia<br />
Study or subgroup DHA-P AS+MQ Risk Ratio Weight Risk Ratio<br />
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI<br />
Ashley 2003b THA 3/131 9/131 38.4 % 0.33 [ 0.09, 1.20 ]<br />
Janssens 2003 KHM 4/181 5/190 20.8 % 0.84 [ 0.23, 3.08 ]<br />
Ashley 2004 THA 3/292 7/137 40.7 % 0.20 [ 0.05, 0.77 ]<br />
Subtotal (95% CI) 604 458 100.0 % 0.39 [ 0.19, 0.79 ]<br />
Total events: 10 (DHA-P), 21 (AS+MQ)<br />
Heterogeneity: Chi 2 = 2.34, df = 2 (P = 0.31); I 2 =15%<br />
Test <strong>for</strong> overall effect: Z = 2.58 (P = 0.0099)<br />
2 South America<br />
Grande 2005 PER 4/211 0/224 100.0 % 9.55 [ 0.52, 176.35 ]<br />
Subtotal (95% CI) 211 224 100.0 % 9.55 [ 0.52, 176.35 ]<br />
Total events: 4 (DHA-P), 0 (AS+MQ)<br />
Heterogeneity: not applicable<br />
Test <strong>for</strong> overall effect: Z = 1.52 (P = 0.13)<br />
0.005 0.1 1 10 200<br />
Favours DHA-P Favours AS+MQ<br />
<strong>Artemisinin</strong>-<strong>based</strong> <strong>combination</strong> <strong>therapy</strong> <strong>for</strong> treating uncomplicated malaria (Review)<br />
Copyright © 2009 <strong>The</strong> <strong>Cochrane</strong> Collaboration. Published by John Wiley & Sons, Ltd.<br />
124